| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420530 Polymaleic acid polymer or copolymer with acrylic acid, maleic anhydride, ethyl acrylate or vinyl acetate |
| 07/16/2002 | US6420527 Peoteins with modified amino acid sequences and monellin protein |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420152 Bacterial enzymatic polypeptide for use in detection of infection |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420140 Production of multimeric protein by cell fusion method |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420126 Tumor specific internalizing antigens and methods for targeting therapeutic agents |
| 07/16/2002 | US6420125 Measurement of degradation of collagen; obtain body fluid, monitor concentration of collagen in fluid |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420116 Protein for use in the human therapeutics and diagnosis |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6419944 Cytokine antagonists for the treatment of localized disorders |
| 07/16/2002 | US6419934 Administering tumor necrosis factor antagonist |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use |
| 07/16/2002 | US6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages |
| 07/16/2002 | US6419926 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419924 Prevent membrane formation; antiproliferative agents; antitumor agents |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | CA2097200C Protein tyrosine kinase |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/16/2002 | CA1341377C Composition and method for acceleration of clot lysis |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053595A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/11/2002 | WO2002053179A1 The method for the production of the egg containing anti-pathogenic bacteria specific antibodies (igy) and the yogurt and ice cream contaiing the igy |
| 07/11/2002 | WO2002053177A2 Agents and methods for treating pain |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002027019A8 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001083781A3 14094, a novel human trypsin family member and uses thereof |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | WO2001015729A9 Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
| 07/11/2002 | WO2001012816A3 Porcine endovirus gag and env and diagnostic uses thereof |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 07/11/2002 | WO2000077486A3 Compositions and methods for detecting treponema pallidum |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091234 Adjuvant for enhancing immune response to preferential immunogen |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020091082 Inhibiting VEGF-KDR signaling pathway components, e.g., PKC-zeta and/or PI3 kinase 1. |
| 07/11/2002 | US20020091081 Administering therapeutically active dosages of peptides containing specific amino acid sequences or antibodies that bind to cell membrane antigens on the surface of rapidly dividing endothelial cells. |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090681 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090660 Helicobacter pylori antigens in blood |
| 07/11/2002 | US20020090658 Diagnosing connective tissue defects; obtain sample, screen sample for the presence of degradation protein, amplified concentrations of protein indicate connective tissue defects |
| 07/11/2002 | US20020090657 Detecting preferential binding particle in sample; obtain cell, incubate with modulator, monitor forming of complex, compare to control, reduction in complex formation indicates bound receptor |
| 07/11/2002 | US20020090654 Polypeptide for use in the treatment of collagenase defects |
| 07/11/2002 | US20020090651 Isolated FGF receptor |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090370 Novel porcine protein and uses thereof |
| 07/11/2002 | US20020090366 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 07/11/2002 | DE10065227A1 Separating antibody isotypes from egg yolk, useful for immunization and immunoassay, comprises fractional salting out from aqueous yolk fraction |
| 07/11/2002 | DE10063048A1 Einzelketten-Antikörper mit verbesserter Stabilität Single-chain antibody with improved stability |
| 07/11/2002 | CA2434129A1 Degradation and detection of prion infectivity |